Search Results for “FDA” – Page 164 – media

Spero Gets Grant of $54M for Biodefense R&D for SPR994

Spero Therapeutics granted $15.7 million for research on SPR994, its oral carbapenem-class candidate, to study the drug’s efficacy against biological threats like anthrax, plague and melioidosis as a part of an interagency collaboration.
- Source: FierceBiotech
- 797
- July 18, 2018
biotech Company Insight
Red Wine and Green Tea could Treat Congenital Inborn Metabolic Diseases

A research team from Tel Aviv University suggested that red wine and green tea could treat certain congenital metabolic diseases, by blocking toxic metabolite formations. Since people with inborn metabolic disorders are born with a defective gene, it leads to a critical enzyme deficiency. Since there is no cure, many patients with congenital metabolic disorders are required to follow a lifelong strict diet.
- Source: Science Daily
- 540
- July 10, 2018
metabolic disease Researches
PharmaAsia Recap

Recent news regarding pharma companies in Asia
- Source: FiercePharma
- 728
- July 3, 2018
Asia Market Views pharmaceutical company
Biotech Crinetics Therapeutics Raises $86 million in IPO

The San Diego-based biotech company Crinetics Therapeutics recently raised $86 million in an IPO. Prior to the new funding, the company received $63.5 million in series B funding and will see its lead asset through phase 2.
- Source: FierceBiotech
- 790
- June 26, 2018
biotech Clinical Trials endocrine disorders
Indian Healthcare Startup SigTuple Raised $19 Million AI Based Products Development

India, Bengaluru based SigTuple, a startup focusing on Artificial Intelligence for Healthcare has raised $19 million in their series B funding. The investment was led by IDG Ventures, pi Ventures Partners along with Accel, Axilor Ventures, VH Capital, Endiya Partners and Flipkart’s executive chairman Binny Bansal. The startup has also bagged venture debt from Trifecta Capital in this round. In an earlier investment round, the company raised $6.5 million from various investors.
- Source: Analytics India
- 704
- June 26, 2018
AI Company Insight digital health start ups
Glaukos Corporation to receive Pre-Market approval for Next-Gen iStent

The inject is developed to achieve the natural outflow of aqueous humor by making two patent bypasses through the trabecular meshwork, glaucomatous eyes the main source of resistance resulting in multi-directional flow through Schlemm’s canal
- Source: BioSpectrumAsia
- 542
- June 26, 2018
FDA medtech New Approvals Optometry
Shingrix Orders Limited by GlaxoSmithKline

Order limits have been introduced by GSK owing to high demand for the product, as per a note on the CDC’s website. In the meantime, shipping delays are being experienced by providers and according to the CDC, the delays are likely to remain throughout the year.
- Source: FiercePharma
- 669
- June 22, 2018
GSK Market Views shingles
Remote Patient Monitoring Startup could Spell Major Turning Point in Digital Health

Ambient Clinical Analytics, the remote patient monitoring firm which became independent from Mayo Clinic in 2013, has elevated $1.5 million in a round led by Noaber Ventures. Noaber Ventures is the extended investment arm of Noaber Foundation and the company’s first European investor. The already existing investors such as Mayo Clinic, Bluestem Capital and Social Capital have also contributed to the round.
- Source: MobiHealthNews
- 698
- June 22, 2018
Company Insight digital health EHR
Toothpaste Combats Lung Disease

Cystic fibrosis is the most common lung affecting genetic disease, which often turns out to be life-threatening. Nearly one in every 2500 to 3500 people are diagnosed with cystic fibrosis at an early age. A thick mucus formation in the lungs becomes stuck to bacteria, which leads to a slimy biofilm formation.
- Source: India Times
- 501
- June 21, 2018
cystic fibrosis Researches
Salmonella Warning for Cut Melons

Fresh cut melons sold at popular grocery stores were responsible for nearly 60 people being infected with Salmonella. In order to be sure of what is safe to consume and what not, refer to the list of Food and Drug Administration (FDA) consumable items. Here they state that people need not give up melons entirely but rather only the pre-cut ones.
- Source: HealthLine
- 543
- June 20, 2018
Researches Salmonella

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.